VLS.L - Velocys plc
| Previous close | 2.3500 |
| Open | 2.4500 |
| Bid | 2.3100 x 0 |
| Ask | 2.4000 x 0 |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | 2,902,905 |
| Market cap | 33.544M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings date | 18 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 14.00 |
Simply Wall St.Velocys Full Year 2022 Earnings: Misses Expectations
Velocys ( LON:VLS ) Full Year 2022 Results Key Financial Results Net loss: UK£13.2m (loss widened by 56% from FY 2021...
- Simply Wall St.
Does This Valuation Of Velocys plc (LON:VLS) Imply Investors Are Overpaying?
Key Insights Using the Dividend Discount Model, Velocys fair value estimate is UK£0.026 Current share price of UK£0.034...
Business WireFuse Medical, Inc. Fiscal Year 2022 Financial Results
RICHARDSON, Texas, April 18, 2023--Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Company") an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, filed its annual report on Form 10-K for the year ended December 31, 2022 with the Securities and Exchange Commission ("SEC") on April 14, 2023.
- Simply Wall St.
We Think Velocys (LON:VLS) Needs To Drive Business Growth Carefully
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Business WireFuse Medical, Inc. Announces Third Quarter 2022 Financial Results
RICHARDSON, Texas, November 15, 2022--Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Company") an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced for its third quarter ended September 30, 2022 and that it has filed its quarterly report on Form 10-Q for the quarter ended September 30, 2022 with the Securities and Exchange Commission ("SEC") on November 14, 2022.
- Simply Wall St.
Is Velocys plc (LON:VLS) Expensive For A Reason? A Look At Its Intrinsic Value
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Velocys plc ( LON:VLS...
- Simply Wall St.
Velocys plc's (LON:VLS) high institutional ownership speaks for itself as stock continues to impress, up 20% over last week
If you want to know who really controls Velocys plc ( LON:VLS ), then you'll have to look at the makeup of its share...
Business WireFuse Medical, Inc. Ranked Among Top 150 Public Companies in Dallas-Fort Worth Metroplex
RICHARDSON, Texas, August 23, 2022--Fuse Medical, Inc., (OTCPINK: FZMD), ("Fuse" or the "Company") an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has been ranked number 149 on the 2022 list of Dallas-Fort Worth’s 150 largest public companies, by the Dallas Morning News.
- Simply Wall St.
Investors in Velocys (LON:VLS) have unfortunately lost 90% over the last five years
Long term investing works well, but it doesn't always work for each individual stock. It hits us in the gut when we see...